Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Choroid Plexus | 25 | 2024 | 237 | 11.410 |
Why?
|
Cerebrospinal Fluid | 17 | 2024 | 544 | 5.580 |
Why?
|
Blood-Brain Barrier | 9 | 2024 | 1018 | 2.520 |
Why?
|
Neural Stem Cells | 4 | 2020 | 882 | 1.350 |
Why?
|
Hydrocephalus | 3 | 2023 | 764 | 1.120 |
Why?
|
Cerebral Ventricles | 4 | 2023 | 542 | 1.000 |
Why?
|
Choroid Plexus Neoplasms | 3 | 2022 | 38 | 0.940 |
Why?
|
Cerebral Cortex | 7 | 2023 | 5759 | 0.890 |
Why?
|
Central Nervous System | 6 | 2021 | 1333 | 0.890 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2023 | 263 | 0.800 |
Why?
|
Epithelial Cells | 7 | 2024 | 3665 | 0.800 |
Why?
|
Neurons | 15 | 2019 | 9418 | 0.790 |
Why?
|
Neurogenesis | 6 | 2024 | 855 | 0.730 |
Why?
|
Lateral Ventricles | 3 | 2019 | 146 | 0.730 |
Why?
|
Fourth Ventricle | 2 | 2021 | 32 | 0.680 |
Why?
|
Adult Stem Cells | 2 | 2019 | 221 | 0.680 |
Why?
|
Prosencephalon | 2 | 2019 | 305 | 0.680 |
Why?
|
Potassium | 2 | 2023 | 1310 | 0.660 |
Why?
|
Proteome | 3 | 2019 | 1855 | 0.640 |
Why?
|
Mice | 34 | 2024 | 81107 | 0.610 |
Why?
|
Ciliary Body | 1 | 2018 | 166 | 0.570 |
Why?
|
Language Development | 1 | 2018 | 181 | 0.570 |
Why?
|
Craniofacial Abnormalities | 1 | 2019 | 315 | 0.560 |
Why?
|
Lipopolysaccharides | 1 | 2024 | 2204 | 0.550 |
Why?
|
Sodium Channels | 1 | 2018 | 343 | 0.540 |
Why?
|
Animals | 47 | 2024 | 167777 | 0.540 |
Why?
|
Epithelium | 4 | 2022 | 1605 | 0.530 |
Why?
|
Microcephaly | 2 | 2019 | 425 | 0.530 |
Why?
|
Brain | 14 | 2024 | 26951 | 0.520 |
Why?
|
Neurodegenerative Diseases | 3 | 2017 | 1081 | 0.510 |
Why?
|
Neural Tube | 1 | 2015 | 48 | 0.510 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2019 | 557 | 0.510 |
Why?
|
Oxidative Stress | 4 | 2022 | 3100 | 0.490 |
Why?
|
Unverricht-Lundborg Syndrome | 2 | 2016 | 2 | 0.480 |
Why?
|
Ribosomes | 1 | 2018 | 501 | 0.480 |
Why?
|
Zebrafish | 3 | 2023 | 2993 | 0.480 |
Why?
|
Growth Disorders | 1 | 2019 | 653 | 0.470 |
Why?
|
Antioxidants | 1 | 2022 | 1662 | 0.470 |
Why?
|
Organoids | 1 | 2020 | 729 | 0.460 |
Why?
|
Pericytes | 1 | 2017 | 293 | 0.460 |
Why?
|
Amniotic Fluid | 1 | 2015 | 378 | 0.440 |
Why?
|
Stem Cell Niche | 1 | 2016 | 345 | 0.430 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18125 | 0.430 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2013 | 72 | 0.420 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 989 | 0.410 |
Why?
|
Macrophages | 2 | 2024 | 5737 | 0.400 |
Why?
|
Neutrophils | 1 | 2024 | 3765 | 0.380 |
Why?
|
Embryo, Mammalian | 4 | 2024 | 1674 | 0.380 |
Why?
|
Light | 1 | 2017 | 1345 | 0.370 |
Why?
|
Down-Regulation | 1 | 2018 | 2905 | 0.370 |
Why?
|
Autistic Disorder | 1 | 2020 | 1216 | 0.360 |
Why?
|
Hippocampus | 3 | 2022 | 3736 | 0.360 |
Why?
|
Sleep Deprivation | 1 | 2017 | 840 | 0.350 |
Why?
|
Tight Junctions | 2 | 2024 | 317 | 0.350 |
Why?
|
Cell Death | 5 | 2015 | 1667 | 0.350 |
Why?
|
Cystathionine gamma-Lyase | 1 | 2009 | 36 | 0.330 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2018 | 3602 | 0.330 |
Why?
|
Behavior | 1 | 2012 | 540 | 0.320 |
Why?
|
Signal Transduction | 15 | 2024 | 23341 | 0.320 |
Why?
|
Biological Transport | 3 | 2023 | 2084 | 0.320 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 3826 | 0.320 |
Why?
|
Hedgehog Proteins | 4 | 2022 | 769 | 0.310 |
Why?
|
Neuroepithelial Cells | 2 | 2019 | 23 | 0.310 |
Why?
|
Aging | 3 | 2022 | 8651 | 0.300 |
Why?
|
Fear | 1 | 2016 | 1462 | 0.290 |
Why?
|
Calcium | 1 | 2020 | 5721 | 0.290 |
Why?
|
Longevity | 2 | 2023 | 1050 | 0.280 |
Why?
|
Attention | 1 | 2017 | 2387 | 0.270 |
Why?
|
Mitochondria | 1 | 2019 | 3584 | 0.270 |
Why?
|
Cell Differentiation | 5 | 2021 | 11471 | 0.270 |
Why?
|
Retina | 1 | 2017 | 2637 | 0.260 |
Why?
|
Mice, Inbred C57BL | 8 | 2024 | 22006 | 0.260 |
Why?
|
Apoptosis | 3 | 2019 | 9468 | 0.250 |
Why?
|
Migraine Disorders | 1 | 2017 | 1694 | 0.240 |
Why?
|
Animals, Newborn | 4 | 2021 | 2673 | 0.230 |
Why?
|
Cerebral Hemorrhage | 3 | 2024 | 2650 | 0.220 |
Why?
|
Forkhead Transcription Factors | 2 | 2009 | 1611 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2024 | 225 | 0.200 |
Why?
|
Insulin-Like Growth Factor II | 2 | 2016 | 268 | 0.200 |
Why?
|
Prealbumin | 1 | 2023 | 222 | 0.190 |
Why?
|
Schizophrenia | 1 | 2020 | 6913 | 0.190 |
Why?
|
Histone Demethylases | 1 | 2024 | 319 | 0.190 |
Why?
|
Injections, Intraventricular | 1 | 2021 | 225 | 0.180 |
Why?
|
Inflammation | 1 | 2020 | 10719 | 0.180 |
Why?
|
Thyroid Hormones | 1 | 2023 | 403 | 0.180 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2019 | 695 | 0.180 |
Why?
|
Cell Proliferation | 5 | 2020 | 10417 | 0.170 |
Why?
|
Brain Injuries | 1 | 2012 | 2044 | 0.170 |
Why?
|
Rats | 8 | 2023 | 23681 | 0.170 |
Why?
|
Isonicotinic Acids | 1 | 2019 | 8 | 0.170 |
Why?
|
Mice, Transgenic | 5 | 2021 | 9518 | 0.170 |
Why?
|
Serotonin Receptor Agonists | 1 | 2020 | 151 | 0.170 |
Why?
|
Receptors, CCR2 | 1 | 2020 | 215 | 0.170 |
Why?
|
Ependyma | 1 | 2019 | 56 | 0.160 |
Why?
|
Humans | 40 | 2024 | 758381 | 0.160 |
Why?
|
GABA Agonists | 1 | 2019 | 105 | 0.160 |
Why?
|
Cells, Cultured | 8 | 2018 | 18942 | 0.160 |
Why?
|
Cerebellum | 5 | 2017 | 1497 | 0.160 |
Why?
|
Embryonic Development | 1 | 2024 | 716 | 0.160 |
Why?
|
Nerve Tissue Proteins | 3 | 2019 | 4406 | 0.160 |
Why?
|
Intracranial Pressure | 1 | 2021 | 325 | 0.160 |
Why?
|
Translocation, Genetic | 1 | 2024 | 1387 | 0.160 |
Why?
|
Female | 23 | 2024 | 390316 | 0.150 |
Why?
|
Microfilament Proteins | 2 | 2020 | 1133 | 0.150 |
Why?
|
Gene Knock-In Techniques | 1 | 2019 | 419 | 0.150 |
Why?
|
Cell Count | 1 | 2022 | 1835 | 0.150 |
Why?
|
Chemokine CCL2 | 1 | 2020 | 604 | 0.150 |
Why?
|
Cell Lineage | 2 | 2021 | 2533 | 0.150 |
Why?
|
Ferrets | 1 | 2018 | 177 | 0.150 |
Why?
|
Macrophage Activation | 1 | 2020 | 552 | 0.150 |
Why?
|
Metabolome | 1 | 2024 | 982 | 0.150 |
Why?
|
Nuclear Proteins | 3 | 2022 | 5787 | 0.140 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 150 | 0.140 |
Why?
|
Touch | 1 | 2019 | 312 | 0.140 |
Why?
|
Cystatin B | 1 | 2016 | 12 | 0.140 |
Why?
|
Neoplasms | 2 | 2024 | 22030 | 0.140 |
Why?
|
Photophobia | 1 | 2017 | 71 | 0.140 |
Why?
|
Optic Atrophy | 1 | 2017 | 78 | 0.140 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 1751 | 0.130 |
Why?
|
Pregnancy | 4 | 2024 | 29742 | 0.130 |
Why?
|
Immunoblotting | 1 | 2019 | 1647 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2024 | 1594 | 0.130 |
Why?
|
Calcium-Binding Proteins | 1 | 2020 | 1066 | 0.130 |
Why?
|
Dependovirus | 1 | 2021 | 711 | 0.130 |
Why?
|
Methotrexate | 1 | 2022 | 1719 | 0.130 |
Why?
|
Male | 16 | 2024 | 358742 | 0.130 |
Why?
|
Glycolysis | 1 | 2019 | 826 | 0.130 |
Why?
|
Spinal Cord | 1 | 2023 | 1815 | 0.130 |
Why?
|
Immunity | 1 | 2021 | 998 | 0.120 |
Why?
|
Papillomaviridae | 2 | 2001 | 1121 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2020 | 1177 | 0.120 |
Why?
|
Viral Vaccines | 1 | 2000 | 596 | 0.120 |
Why?
|
Monocytes | 1 | 2024 | 2570 | 0.120 |
Why?
|
Retinoids | 1 | 2015 | 98 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2024 | 2416 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 4567 | 0.120 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2015 | 94 | 0.120 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2019 | 607 | 0.120 |
Why?
|
Cognition | 2 | 2024 | 6955 | 0.120 |
Why?
|
Sensory Receptor Cells | 1 | 2019 | 509 | 0.120 |
Why?
|
Nucleoside-Phosphate Kinase | 2 | 2011 | 24 | 0.120 |
Why?
|
Papillomavirus Vaccines | 1 | 2000 | 497 | 0.120 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2015 | 121 | 0.110 |
Why?
|
Capillaries | 1 | 2017 | 744 | 0.110 |
Why?
|
Conditioning, Classical | 1 | 2016 | 365 | 0.110 |
Why?
|
Spasms, Infantile | 1 | 2017 | 296 | 0.110 |
Why?
|
Infant | 6 | 2020 | 36054 | 0.110 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2001 | 2016 | 0.110 |
Why?
|
Receptor, Notch1 | 1 | 2016 | 495 | 0.110 |
Why?
|
HEK293 Cells | 2 | 2021 | 4258 | 0.110 |
Why?
|
Brain Edema | 1 | 2017 | 603 | 0.100 |
Why?
|
Tretinoin | 2 | 2015 | 519 | 0.100 |
Why?
|
Models, Biological | 3 | 2010 | 9461 | 0.100 |
Why?
|
Stem Cells | 3 | 2015 | 3521 | 0.100 |
Why?
|
Brain Diseases | 1 | 2021 | 1541 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1878 | 0.100 |
Why?
|
Memory | 2 | 2024 | 2179 | 0.100 |
Why?
|
Up-Regulation | 1 | 2020 | 4114 | 0.100 |
Why?
|
Analysis of Variance | 2 | 2011 | 6233 | 0.100 |
Why?
|
Dissection | 1 | 2013 | 297 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2021 | 3380 | 0.090 |
Why?
|
Adherens Junctions | 1 | 2011 | 89 | 0.090 |
Why?
|
Trisomy | 1 | 2012 | 260 | 0.090 |
Why?
|
Cerebrum | 1 | 2012 | 132 | 0.090 |
Why?
|
Pedigree | 1 | 2018 | 4578 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3443 | 0.090 |
Why?
|
Carcinoma | 1 | 2022 | 2330 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 867 | 0.090 |
Why?
|
Malformations of Cortical Development | 1 | 2012 | 176 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3758 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2379 | 0.090 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2012 | 635 | 0.090 |
Why?
|
Olfactory Mucosa | 1 | 2010 | 99 | 0.080 |
Why?
|
Galactosides | 1 | 2009 | 54 | 0.080 |
Why?
|
Mice, Knockout | 5 | 2024 | 14354 | 0.080 |
Why?
|
Cell Movement | 2 | 2018 | 5201 | 0.080 |
Why?
|
Cathepsin B | 1 | 2009 | 80 | 0.080 |
Why?
|
Zebrafish Proteins | 1 | 2015 | 1006 | 0.080 |
Why?
|
Cell Communication | 1 | 2016 | 1651 | 0.080 |
Why?
|
Oxidants | 1 | 2009 | 169 | 0.080 |
Why?
|
Receptor, IGF Type 1 | 1 | 2011 | 380 | 0.080 |
Why?
|
Macaca mulatta | 1 | 2015 | 2316 | 0.080 |
Why?
|
Age Factors | 3 | 2021 | 18357 | 0.080 |
Why?
|
Cell Polarity | 1 | 2011 | 638 | 0.080 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2006 | 435 | 0.070 |
Why?
|
14-3-3 Proteins | 2 | 2006 | 221 | 0.070 |
Why?
|
Hepatocyte Growth Factor | 1 | 2009 | 267 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4048 | 0.070 |
Why?
|
Receptors, Notch | 1 | 2011 | 743 | 0.070 |
Why?
|
Synapses | 1 | 2016 | 1757 | 0.070 |
Why?
|
Child, Preschool | 5 | 2018 | 42058 | 0.070 |
Why?
|
Adult | 10 | 2019 | 219916 | 0.060 |
Why?
|
Hydrogen Peroxide | 1 | 2009 | 728 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2024 | 26182 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4192 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2850 | 0.060 |
Why?
|
PTEN Phosphohydrolase | 1 | 2011 | 1113 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 11894 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1171 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2024 | 4485 | 0.060 |
Why?
|
Cell Survival | 5 | 2017 | 5781 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1651 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2057 | 0.060 |
Why?
|
Transfection | 2 | 2009 | 5779 | 0.060 |
Why?
|
Glutamic Acid | 1 | 2009 | 1167 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2443 | 0.050 |
Why?
|
Receptor, trkA | 1 | 2024 | 159 | 0.050 |
Why?
|
Oxidation-Reduction | 1 | 2009 | 2222 | 0.050 |
Why?
|
Conserved Sequence | 1 | 2006 | 1165 | 0.050 |
Why?
|
Transcriptional Activation | 2 | 2006 | 1753 | 0.050 |
Why?
|
Cerebellar Cortex | 1 | 2003 | 107 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2008 | 3593 | 0.050 |
Why?
|
Pain | 1 | 2017 | 5065 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16534 | 0.050 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 43 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2016 | 12760 | 0.050 |
Why?
|
CDC2 Protein Kinase | 1 | 2002 | 213 | 0.050 |
Why?
|
Finland | 2 | 2000 | 603 | 0.050 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2001 | 180 | 0.050 |
Why?
|
Child | 5 | 2018 | 79813 | 0.050 |
Why?
|
Phosphorylation | 3 | 2009 | 8297 | 0.050 |
Why?
|
Adolescent | 5 | 2018 | 87888 | 0.050 |
Why?
|
Prostaglandins | 1 | 2001 | 398 | 0.040 |
Why?
|
Calcitonin | 1 | 2001 | 330 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3433 | 0.040 |
Why?
|
Adrenergic beta-Agonists | 1 | 2001 | 344 | 0.040 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2001 | 361 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2003 | 597 | 0.040 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2006 | 866 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3796 | 0.040 |
Why?
|
Chlamydia trachomatis | 1 | 2001 | 239 | 0.040 |
Why?
|
Mutation | 2 | 2024 | 29915 | 0.040 |
Why?
|
Microglia | 2 | 2024 | 1349 | 0.040 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2019 | 187 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 39873 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2006 | 1885 | 0.040 |
Why?
|
Maze Learning | 1 | 2019 | 477 | 0.040 |
Why?
|
Oligodendroglia | 1 | 2001 | 537 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2001 | 1455 | 0.040 |
Why?
|
Caenorhabditis elegans | 1 | 2006 | 1444 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2011 | 7843 | 0.040 |
Why?
|
Anxiety | 2 | 2024 | 4538 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2018 | 670 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7590 | 0.030 |
Why?
|
Glioblastoma | 1 | 2011 | 3480 | 0.030 |
Why?
|
Vesicular Transport Proteins | 1 | 2018 | 374 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2016 | 372 | 0.030 |
Why?
|
Metabolomics | 1 | 2024 | 1629 | 0.030 |
Why?
|
Cell Line | 3 | 2021 | 15594 | 0.030 |
Why?
|
Infant, Premature | 1 | 2024 | 2092 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9405 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2638 | 0.030 |
Why?
|
Blotting, Western | 2 | 2016 | 5031 | 0.030 |
Why?
|
Hypertrophy | 1 | 2015 | 555 | 0.030 |
Why?
|
Transcription Factors | 3 | 2017 | 12096 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36285 | 0.030 |
Why?
|
Edema | 1 | 2017 | 768 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1610 | 0.030 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1842 | 0.030 |
Why?
|
Chromatin | 1 | 2024 | 2938 | 0.030 |
Why?
|
Disease Progression | 1 | 2009 | 13468 | 0.020 |
Why?
|
Action Potentials | 1 | 2019 | 1816 | 0.020 |
Why?
|
Cilia | 1 | 2016 | 493 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2019 | 1867 | 0.020 |
Why?
|
Young Adult | 1 | 2018 | 58808 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 9575 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1969 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5779 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2000 | 5199 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2011 | 8981 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2002 | 4937 | 0.020 |
Why?
|
Electroporation | 1 | 2010 | 254 | 0.020 |
Why?
|
Organogenesis | 1 | 2010 | 215 | 0.020 |
Why?
|
Leukemia | 1 | 1996 | 1519 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6127 | 0.020 |
Why?
|
Middle Aged | 5 | 2018 | 219560 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2010 | 11070 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2024 | 5629 | 0.020 |
Why?
|
Herpesviridae Infections | 1 | 1989 | 270 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2017 | 2564 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 1989 | 319 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16886 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3774 | 0.020 |
Why?
|
Lymphoma | 1 | 1996 | 1896 | 0.020 |
Why?
|
Pilot Projects | 1 | 2000 | 8554 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 1993 | 663 | 0.020 |
Why?
|
Gene Targeting | 1 | 2010 | 837 | 0.020 |
Why?
|
Tumor Virus Infections | 1 | 1989 | 438 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4711 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2001 | 4023 | 0.020 |
Why?
|
Antibodies | 1 | 1993 | 2420 | 0.010 |
Why?
|
Lithium Chloride | 1 | 2004 | 82 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2000 | 7985 | 0.010 |
Why?
|
Potassium Chloride | 1 | 2004 | 230 | 0.010 |
Why?
|
Incidence | 2 | 2000 | 21273 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 1989 | 1745 | 0.010 |
Why?
|
Neurotrophin 3 | 1 | 2003 | 61 | 0.010 |
Why?
|
Myogenic Regulatory Factors | 1 | 2003 | 103 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2003 | 66 | 0.010 |
Why?
|
Tumor Microenvironment | 1 | 2016 | 3840 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2004 | 381 | 0.010 |
Why?
|
bcl-Associated Death Protein | 1 | 2002 | 102 | 0.010 |
Why?
|
Cell Cycle | 1 | 2010 | 2930 | 0.010 |
Why?
|
Isoproterenol | 1 | 2001 | 394 | 0.010 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2002 | 370 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 490 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2010 | 2057 | 0.010 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2001 | 213 | 0.010 |
Why?
|
Serotyping | 1 | 2001 | 324 | 0.010 |
Why?
|
Cotinine | 1 | 2001 | 203 | 0.010 |
Why?
|
Cytoplasm | 1 | 2004 | 1514 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8506 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2872 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2275 | 0.010 |
Why?
|
Growth Substances | 1 | 2001 | 768 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1996 | 5129 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1245 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 1996 | 5649 | 0.010 |
Why?
|
Serine | 1 | 2002 | 828 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2001 | 1339 | 0.010 |
Why?
|
Chlamydia Infections | 1 | 2001 | 365 | 0.010 |
Why?
|
Risk Factors | 2 | 2001 | 73806 | 0.010 |
Why?
|
Epilepsy | 1 | 2012 | 3269 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2003 | 1477 | 0.010 |
Why?
|
RNA Interference | 1 | 2004 | 2836 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2001 | 1456 | 0.010 |
Why?
|
Rabbits | 1 | 2002 | 4771 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2004 | 2907 | 0.010 |
Why?
|
Kinetics | 1 | 2003 | 6371 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1996 | 881 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2001 | 1468 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 1996 | 13591 | 0.010 |
Why?
|
Astrocytes | 1 | 2001 | 1337 | 0.010 |
Why?
|
Social Security | 1 | 1993 | 101 | 0.010 |
Why?
|
Logistic Models | 2 | 2001 | 13276 | 0.010 |
Why?
|
Mobile Health Units | 1 | 1993 | 92 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1996 | 2114 | 0.010 |
Why?
|
Medical Record Linkage | 1 | 1993 | 286 | 0.010 |
Why?
|
Registries | 2 | 2001 | 8176 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 2001 | 14481 | 0.010 |
Why?
|
Remission Induction | 1 | 1996 | 2388 | 0.010 |
Why?
|
Salvage Therapy | 1 | 1996 | 1268 | 0.010 |
Why?
|
Aged | 4 | 2015 | 168217 | 0.010 |
Why?
|
Protein Binding | 1 | 2002 | 9312 | 0.010 |
Why?
|
Ploidies | 1 | 1989 | 275 | 0.010 |
Why?
|
Burkitt Lymphoma | 1 | 1989 | 333 | 0.000 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1989 | 286 | 0.000 |
Why?
|
Causality | 1 | 1993 | 1241 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1996 | 8530 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1996 | 10747 | 0.000 |
Why?
|
Recurrence | 1 | 1996 | 8426 | 0.000 |
Why?
|
Herpesvirus 4, Human | 1 | 1989 | 1075 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2001 | 22031 | 0.000 |
Why?
|
Population Surveillance | 1 | 1993 | 2606 | 0.000 |
Why?
|
Hodgkin Disease | 1 | 1989 | 1377 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1989 | 5864 | 0.000 |
Why?
|
Mass Screening | 1 | 1993 | 5425 | 0.000 |
Why?
|
Smoking | 1 | 1993 | 9042 | 0.000 |
Why?
|
Prevalence | 1 | 1993 | 15646 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1993 | 39060 | 0.000 |
Why?
|
Treatment Outcome | 1 | 1996 | 64379 | 0.000 |
Why?
|
Prospective Studies | 1 | 1993 | 54136 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1996 | 80170 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1989 | 58681 | 0.000 |
Why?
|